logo Kompas.id
EnglishTwo homegrown Covid-19...
Iklan

Two homegrown Covid-19 Vaccines Receives the Go-Ahead

The Indovac Covid-19 vaccine was developed by state-owned pharmaceutical firm PT Bio Farma, while the AWcorna Covid-19 vaccine was developed by PT Etana Biotechnologies Indonesia.

By
NASRULLAH NARA
· 5 minutes read
Medical personnel inject the third dose of Covid-19 vaccine (booster) to workers at the Kompas Tower, Jakarta,  on Tuesday (25/1/2022).
KOMPAS/HERU SRI KUMORO

Medical personnel inject the third dose of Covid-19 vaccine (booster) to workers at the Kompas Tower, Jakarta, on Tuesday (25/1/2022).

JAKARTA, KOMPAS - The Food and Drug Monitoring Agency (BPOM) issued emergency use authorizations (EUA) for two locally developed Covid-19 vaccines, namely the Indovac vaccine and the AWcorna vaccine. The granting of the EUAs also reflects Indonesia’s increasing independence in vaccine production.

The Indovac Covid-19 vaccine was developed by state-owned pharmaceutical firm PT Bio Farma, while the AWcorna Covid-19 vaccine was developed by PT Etana Biotechnologies Indonesia. The EUAs guarantee both vaccines’ efficacy and safety.

Editor:
NASRULLAH NARA
Share
Logo Kompas
Logo iosLogo android
Kantor Redaksi
Menara Kompas Lantai 5, Jalan Palmerah Selatan 21, Jakarta Pusat, DKI Jakarta, Indonesia, 10270.
+6221 5347 710
+6221 5347 720
+6221 5347 730
+6221 530 2200
Kantor Iklan
Menara Kompas Lantai 2, Jalan Palmerah Selatan 21, Jakarta Pusat, DKI Jakarta, Indonesia, 10270.
+6221 8062 6699
Layanan Pelanggan
Kompas Kring
+6221 2567 6000